The hybridoma cell lines M 1/70 (13) and 2.4G2 (14) were generously provided by Dr. T. A. Springer, Boston and Dr. J. C. Unkeless, New York, respectively.
Complement. Fresh normal serum from DBA/2 C5-deficient mice was used as a source of complement.
Cobra Venom Factor. A purified preparation was generously provided by Professor Otto G6tze, G6ttingen, FRG.
Enhancement Assay. WNV at 200-300 pfu/ml (as measured by conventional assay on a pig kidney cell line [PS] ; reference 15) was mixed with an equal volume of rabbit anti-WNV IgM at 1:40 dilution, or diluent, and incubated at 37°C for 45 min. Aliquots of these mixtures, 0.1 ml, were applied to two to four preformed cell monolayers followed immediately by 0.1 ml of a 1:3 dilution of fresh or heat-inactivated (56°C for 30 min) DBA/2 mouse serum. After 2 h at 37°C monolayers were washed twice with PBS to remove residual virus, a carboxymethylcellulose overlay medium was added, and preparations were incubated at 37°C for 3 d, at which time plaques were stained with naphthalene black and counted.
Results
When IgM at a dilution of 1:40 was incubated with WNV and the residual infectivity of the mixture assayed on L929 fibroblasts, neutralization occurred, which was further potentiated in the presence of fresh normal serum obtained from DBA/2 C5-deficient mice, as would be expected (Fig. 1 a) (16) . When the Mq5 line P388D1 was infected under the same conditions, however, there was a 5-10-fold increase in plaques produced by mixtures containing IgM, virus, and fresh serum (Fig. 1 b) . Serum heat inactivated at 56°C for 30 min did not mediate this increase. Control infections in which virus was incubated without IgM and presented to the cells in the presence of fresh normal serum did not show increased viral replication. Fresh serum diluted 1:2 to 1:12 was capable of enhancing viral replication; IgM enhanced viral replication when used at 1:10 to 1:160, neutralization was never observed with P388D1 cells in the presence of fresh normal serum (data not shown).
To further investigate the nature of the heat labile component(s) responsible for this effect, we utilized highly purified cobra venom factor (CVF) which consumes mainly C3 in the C5-deficient mouse serum used here. Fresh serum treated with CVF did not enhance replication of the IgM-virus mixtures ( Fig. 
c).
Once activated by limited proteolysis, complement components, C3, C4, and the anti-proteinase a2 macroglobulin bind covalently to other molecules in a reaction mediated by an activated thiol ester. Nucleophiles that react with this thiol ester prevent covalent binding to other molecules (17) . We used the strong nucleophile sodium salicylhydroxamate to compete with virus mixtures for the covalent binding site of the serum components involved. The ADE observed with IgM-virus-fresh serum was decreased with increasing concentrations of sodium salicylhydroxamate and was completely abolished by 0.7 mM of the salt, which did not affect macrophage viability or viral growth in the absence of fresh serum (data not shown). Abrogation of ADE by CVF and by sodium salicylhydroxamate are compatible with a role for C3.
Investigations of the M~b membrane receptors that might be implicated indicate that CR3, which recognizes iC3b (a rapidly formed major fragment of activated C3) is involved in the binding step. When P388D1 cells were preincubated with M1/70, which inhibits CR3-mediated binding of opsonized erythrocytes (13) ADE of the IgM-virus-fresh serum mixture was abolished, whereas 2.4G2, directed against the trypsin-resistant Fc receptor 04) had no effect (Fig. 2a) . Under our experimental conditions, neither M 1/70 nor 2.4G2 affected controls in the absence of IgM. In contrast, ADE mediated by IgG1 was not affected by either fresh serum or M1/70 but was abrogated by 2.4G2 antibody. Since the cells were preincubated with the monoclonal antibodies M 1/70 and 2.4G2 and washed free of unbound antibody before introduction of virus, these studies implicate macrophage CR3 in IgM-serum enhanced replication of WNV.
Discussion
In these studies the magnitude of the enhancement system is much less than in IgG-mediated ADE. However, 20-50-fold enhancement has been observed when thiog]ycollate-elicited, but not resident, mouse peritoneal macrophages are infected with virus-IgM-fresh serum (unpublished observations). These differences may be related to observations that certain Mq~ ingest opsonized particles readily via Fc receptors (7, 9) but fail to ingest particles bound via complement receptors (7, 9, 10) unless the cells are stimulated by various treatments (9, (18) (19) (20) or the particles coated with both IgG and complement (10) .
In the experiments presented here, we have deliberately separated Fc receptordependent ADE, mediated by IgG, from enhancement via complement receptors and IgM. The two enhancement pathways are not mutually exclusive, but may act synergistically when certain classes of IgG fix complement. Complement receptors are found on many cell types (21) (erythrocytes, lymphocytes, neutrophils, monocytes, macrophages, kidney epithelial cells) and there may be several different complement receptors on each cell type. Although it remains to be shown that other complement receptors can also mediate enhanced viral replication, we suspect that enhancement via complement receptors may be a general phenomenon. Since some enveloped viruses are able to activate complement in the absence of antibody (22, 23) , such a route of virus penetration should be considered seriously in other systems.
Summary
Evidence is presented that M4~ complement receptors (CR3) mediate IgMdependent enhancement of flavivirus replication in the presence of complement. Enhancement is blocked by pretreatment of macrophages with monoclonal antibody M1/70, which inhibits CR3 binding, but not by pretreatment with monoclonal antibody 2.4G2, which inhibits FcR binding.
